254 related articles for article (PubMed ID: 25145691)
21. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
22. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
[TBL] [Abstract][Full Text] [Related]
23. Frequency of diminished ovarian reserve in women with multiple sclerosis in Chile: An exploratory study.
Pelayo C; Ciampi E; Soler B; Uribe-San-Martín R; Reyes A; García L; Del-Canto A; Gutierrez-Carquin L; Barrerra-Hormazabal A; Jürgensen-Heinrich L; Guzman-Cárcamo I; Carvajal A; Troncoso C; Carvajal R; Cárcamo C
Mult Scler Relat Disord; 2023 Nov; 79():105012. PubMed ID: 37797392
[TBL] [Abstract][Full Text] [Related]
24. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
25. Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.
Kato N; Iwase A; Sugita A; Goto M; Nakahara T; Nakamura T; Kondo M; Osuka S; Mori M; Saito A; Kikkawa F
Gynecol Endocrinol; 2015 Jan; 31(1):22-5. PubMed ID: 25030844
[TBL] [Abstract][Full Text] [Related]
26. [Does the serum AMH assay allow predicting reliably female fertility?].
Rolland AL; Dewailly D
Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
[TBL] [Abstract][Full Text] [Related]
27. Anti-Mullerian hormone levels in American girls by age and race/ethnicity.
Elchuri SV; Patterson BC; Brown MR; Buchanan I; Mertens AC; Meacham LR
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):189-93. PubMed ID: 25153582
[TBL] [Abstract][Full Text] [Related]
28. Effects of traditional Korean medicine on anti-Müllerian hormone in patients with diminished ovarian reserve: A retrospective study.
Jo J; Kang MJ; Lee JM; Kim H; Jerng UM
Complement Ther Med; 2016 Feb; 24():118-22. PubMed ID: 26860813
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.
Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F
J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134
[TBL] [Abstract][Full Text] [Related]
30. Serum anti-Müllerian hormone in subfertile women.
Somigliana E; Lattuada D; Colciaghi B; Filippi F; La Vecchia I; Tirelli A; Baffero GM; Paffoni A; Persico N; Bolis G; Fedele L
Acta Obstet Gynecol Scand; 2015 Dec; 94(12):1307-12. PubMed ID: 26332870
[TBL] [Abstract][Full Text] [Related]
31. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.
Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B
Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580
[TBL] [Abstract][Full Text] [Related]
32. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
[TBL] [Abstract][Full Text] [Related]
33. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women.
Schram CA; Stephenson AL; Hannam TG; Tullis E
J Cyst Fibros; 2015 May; 14(3):398-402. PubMed ID: 25280785
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder.
Thöne J; Lichtenberg S; Stahl A; Pache F; Kleiter I; Ruprecht K; Gold R; Hellwig K
Front Neurol; 2018; 9():446. PubMed ID: 29973905
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age.
Kuroda K; Uchida T; Nagai S; Ozaki R; Yamaguchi T; Sato Y; Brosens JJ; Takeda S
J Assist Reprod Genet; 2015 Feb; 32(2):243-7. PubMed ID: 25488203
[TBL] [Abstract][Full Text] [Related]
37. An assessment of anti-Müllerian hormone in predicting mating outcomes in female hamsters that have undergone natural and chemically-accelerated reproductive aging.
Roosa KA; Zysling DA; Place NJ
Gen Comp Endocrinol; 2015 Apr; 214():56-61. PubMed ID: 25801548
[TBL] [Abstract][Full Text] [Related]
38. Anti-Müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies.
Parmova O; Vlckova E; Hulova M; Mensova L; Crha I; Stradalova P; Kralickova E; Jurikova L; Podborska M; Mazanec R; Dusek L; Jarkovsky J; Bednarik J; Vohanka S; Srotova I
Medicine (Baltimore); 2020 Jun; 99(23):e20523. PubMed ID: 32502004
[TBL] [Abstract][Full Text] [Related]
39. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
[TBL] [Abstract][Full Text] [Related]
40. Age-specific values of Access anti-Müllerian hormone immunoassay carried out on Japanese patients with infertility: a retrospective large-scale study.
Segawa T; Omi K; Watanabe Y; Sone Y; Handa M; Kuroda M; Miyauchi O; Osada H; Teramoto S
BMC Womens Health; 2019 Apr; 19(1):57. PubMed ID: 31023297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
